Sign Up Today and Learn More About Commure Stock
Invest in or calculate the value of your shares in Commure or other pre-IPO companies through EquityZen's platform.
Commure Stock (COMM)
FHIR-Compliant Development Platform for Health Systems
About Commure Stock
Founded
2017
Headquarters
San Francisco, CA, US
Total Funding
699M
Industries
Software, Artificial Intelligence, Data and Analytics
Commure aims to provide an FHIR-compliant development platform for health systems, vendors, and startups to build healthcare applications and software. The platform is built with an AAA security framework, an event service bus, an API gateway, a flexible data store, terminology services, and healthcare-specific UI components.
Commure was founded in 2017 by Tim Ellis and Jordan Noone. Notable investors include Human Capital, Quiet Capital, General Catalyst, and Greenoaks Capital.
Commure Press Mentions
Stay in the know about the latest news on Commure
Why Commure, one of healthcare's most deal-hungry startups, plans to buy more scribes
endpoints • Jun 26, 2025
Commure Launches Commure Agents – AI Assistants That Fully Automate Physician Workflows
globenewswire • Jun 25, 2025
Commure Inks $200 Million in Growth Funding
vcnewsdaily • Jun 24, 2025
Financings for June 20, 2025
bioworld • Jun 22, 2025
Commure Raises $200 Million In Growth Financing From General Catalyst's CVF
marketscreener • Jun 21, 2025
Investors in Commure
Discover investors in Commure stock and explore their portfolio companies
Commure Management
Leadership team at Commure
Chief Executive Officer
Ashwini Zenooz
Chief Product and Engineering Officer
Abhijit Mitra
Join now and verify your accreditation status to gain access to:
- Commure Current Valuation
- Commure Stock Price
- Commure Management
- Available deals in Commure and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Commure Cap Table and Funding History by Share Class and Liquidity Preferences
- Commure Revenue and Financials
- Commure Highlights
- Commure Business Model
- Commure Risk Factors
- Commure Research Report from SACRA Research
Trading Commure Stock
How to invest in Commure stock?
Accredited investors can buy pre-IPO stock in companies like Commure through EquityZen funds. These investments are made available by existing Commure shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Commure stock?
Shareholders can sell their Commure stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
